Real-World Overall Survival and Treatment Patterns by PTEN Status in Metastatic Castration-Resistant Prostate Cancer

Medicine, Medical Laboratory Science, Urology, Oncology, Life Sciences, Cell Biology, Biochemistry, Genetics,
PTEN   Castration-Resistant Prostate Cancer   Overall Survival   Treatment Patterns   Genomic Testing  

Overall Survival and Treatment Patterns in Metastatic Castration-Resistant Prostate Cancer Patients Based on PTEN Status Academic Background Prostate cancer is one of the most common malignant tumors among men worldwide and a leading cause of cancer-related deaths. Approximately 10%-20% of prostate cancer patients will develop castration-resistant ...

Circulating and Imaging Biomarkers of Radium-223 Response in Metastatic Castration-Resistant Prostate Cancer

Circulating and Imaging Biomarkers of Radium-223 Response in Metastatic Castration-Resistant Prostate Cancer

Medicine, Medical Laboratory Science, Urology, Medical Imaging, Oncology,
Radium-223   Castration-Resistant Prostate Cancer   Biomarkers   Bone Metastases   Circulating Tumor Cells   Automated Bone Scan Index  

Background of Urgent Problem Prostate cancer is one of the most common cancers among men. Metastatic castration-resistant prostate cancer (mCRPC) is an advanced form of prostate cancer characterized by resistance to castration therapy. Radium-223 is an α-emitting radiopharmaceutical that has been shown to improve overall survival (OS) and reduce sk...